12-53307615-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_015665.6(AAAS):āc.1515T>Cā(p.Pro505=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00147 in 1,614,144 control chromosomes in the GnomAD database, including 37 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0079 ( 20 hom., cov: 33)
Exomes š: 0.00080 ( 17 hom. )
Consequence
AAAS
NM_015665.6 synonymous
NM_015665.6 synonymous
Scores
1
1
8
Clinical Significance
Conservation
PhyloP100: -1.79
Genes affected
AAAS (HGNC:13666): (aladin WD repeat nucleoporin) The protein encoded by this gene is a member of the WD-repeat family of regulatory proteins and may be involved in normal development of the peripheral and central nervous system. The encoded protein is part of the nuclear pore complex and is anchored there by NDC1. Defects in this gene are a cause of achalasia-addisonianism-alacrima syndrome (AAAS), also called triple-A syndrome or Allgrove syndrome. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.005439669).
BP6
Variant 12-53307615-A-G is Benign according to our data. Variant chr12-53307615-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 309722.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.79 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0079 (1203/152340) while in subpopulation AFR AF= 0.0272 (1132/41586). AF 95% confidence interval is 0.0259. There are 20 homozygotes in gnomad4. There are 564 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 20 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AAAS | NM_015665.6 | c.1515T>C | p.Pro505= | synonymous_variant | 16/16 | ENST00000209873.9 | |
AAAS | NM_001173466.2 | c.1416T>C | p.Pro472= | synonymous_variant | 15/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AAAS | ENST00000209873.9 | c.1515T>C | p.Pro505= | synonymous_variant | 16/16 | 1 | NM_015665.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00787 AC: 1198AN: 152222Hom.: 20 Cov.: 33
GnomAD3 genomes
AF:
AC:
1198
AN:
152222
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00195 AC: 489AN: 251124Hom.: 6 AF XY: 0.00152 AC XY: 206AN XY: 135844
GnomAD3 exomes
AF:
AC:
489
AN:
251124
Hom.:
AF XY:
AC XY:
206
AN XY:
135844
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000800 AC: 1169AN: 1461804Hom.: 17 Cov.: 34 AF XY: 0.000674 AC XY: 490AN XY: 727196
GnomAD4 exome
AF:
AC:
1169
AN:
1461804
Hom.:
Cov.:
34
AF XY:
AC XY:
490
AN XY:
727196
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00790 AC: 1203AN: 152340Hom.: 20 Cov.: 33 AF XY: 0.00757 AC XY: 564AN XY: 74508
GnomAD4 genome
AF:
AC:
1203
AN:
152340
Hom.:
Cov.:
33
AF XY:
AC XY:
564
AN XY:
74508
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
92
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
286
Asia WGS
AF:
AC:
10
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Glucocorticoid deficiency with achalasia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
MetaRNN
Benign
T
MutationTaster
Benign
D;D;D
PROVEAN
Benign
N
Sift
Pathogenic
D
MVP
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at